Drospirenone/Ethinyl estradiol

屈螺酮/炔雌醇

Report date: 2026/05/26 20:00:28

Base Information

Drug NameDrospirenone/Ethinyl estradiol
Drug Alias Nameドロスピレノン・エチニルエストラジオール　ベータデクス炔雌醇/屈螺酮Drospirenone - ethinylestradiol mixt屈螺酮炔雌醇片Drospirenone - ethinylestradiol betadex mixt +[16] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonistsEstrogen receptors agonistsMineralocorticoid receptor antagonists +[4] 
TargetsAndrogen ReceptorEstrogen receptorsMineralocorticoid receptor +[4] 
Therapy Area/IndicationsContraceptionBulimia NervosaBinge-Eating Disorder +[10] 
Global Approved IndicationsContraceptionDysmenorrheaEndometriosis
Approved Indications in ChinaContraception
Original Approved Country/TerritoryUnited States
Original Approved Date2001/05/11
Country/TerritoryCanadaUnited StatesThailand +[15] 
CombinationsYes DrospirenoneEthinyl Estradiol
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBio-innova Co LtdMcmaster UniversityBayer AG +[6] 
Inactive CompaniesBayer Pharma AgBayer Weimar Gmbh Und Co KgUniversity Of North Carolina At Chapel Hill +[4] 
Active IndicationsContraceptionBipolar DisorderPremenstrual Dysphoric Disorder +[6] 
Inactive IndicationsBulimia NervosaBinge-Eating DisorderFeeding and Eating Disorders +[4] 

Other Information

ATC CodeG03FA17
Related LinksKEGG